Tudor Borza, MD, MS

 Tudor Borza
Associate Professor of Urology
Medical School
Available to mentor
Tudor Borza, MD, MS
Tudor Borza
Associate Professor
  • Qualifications
  • Center Memberships
  • Recent Publications

  • Manage Your Profile

    • Qualifications
    • Master of Science, Health and Health Care Research
      Rackham Graduate School, University of Michigan, Ann Arbor, Michigan, United States
      2015 - 2016
    • Doctor of Medicine
      University of Michigan Medical School, Ann Arbor, Michigan, United States
      2006 - 2010
    • Bachelor of Science, Chemistry
      Wayne State University, Detroit, Michigan, United States
      2002 - 2006

    Center Memberships
    • Center Member
      Opioid Research Institute
    • Center Member
      Institute for Healthcare Policy and Innovation

    Recent Publications

     See All Publications
    • Presentation
      Novel Application of Patient-Reported Outcomes After Radical Cystectomy
      Borza T. 2026 Sep 23;
    • Journal Article
      Reaching the Unreached: Electronic Decision Aids and the Engagement Gap in Prostate Cancer Screening.
      Qian Z, Radhakrishnan A, Borza T. J Urol, 2026 Sep 2; 101097JU0000000000005289 DOI:10.1097/JU.0000000000005289
      PMID: 42685279
    • Journal Article
      Biopsy Provides Actionable Information Associated with Treatment Decisions for 2–7 cm Renal Masses
      Roadman DF, Shapiro DD, Lotan P, Borza T, Lee ISJ, Hinshaw JL, Lee FT, Golden E, Knavel Koepsel E, Laeseke P, Jarrard DF, Richards KA, Koehne EL, Allen GO, Risk MC, Abel EJ. Cancers, 2026 Sep 1; 18 (17): DOI:10.3390/cancers18172859
    • Presentation
      Outdoor MUSIC: Mount Sinai Medical Center Virtual Grand Rounds Presentation
      Borza T. 2026 Aug 21;
    • Journal Article
      A multilevel intervention to improve adherence to prostate cancer active surveillance versus usual care: results from a pilot randomized controlled trial
      Chen J, Rankin A, Furgal A, Borza T, Skolarus T, Wallner LP, Hawley ST, Radhakrishnan A. BMC Cancer, 2026 Jun 16; DOI:10.1186/s12885-026-16625-8
    • Journal Article
      Survivor-identified barriers and facilitators to acute phase recovery following radical cystectomy
      Marchetti KA, Asees A, Bokil AP, Medich M, Durica KC, Rieker J, Rak K, Borza T, Alcorn ML, Davies BJ, Low CA, Stensland KD, Jacobs BL. Urologic Oncology Seminars and Original Investigations, 2026 Jul 1; 44 (7): 234 - 242. DOI:10.1016/j.urolonc.2026.04.293
    • Proceeding / Abstract / Poster
      Population-level trends in radiation treatment of low-risk prostate cancer.
      Odayar V, Monda S, Yin H, Gonzalez RT, Casas SJ, Hopfensperger K, Kendrick D, Mietzel MA, Mislmani M, Zaki MA, McLaughlin PW, Morgan TM, Jackson WC, Schipper MJ, Heimburger DK, Bryant AK, Pierce LJ, Borza T, Dess RT. Journal of Clinical Oncology, 2026 Mar 4; 44 (7_suppl): 336 - 336. DOI:10.1200/jco.2026.44.7_suppl.336
    • Journal Article
      Incidence and oncologic outcomes of patients with prostate-specific antigen persistence after radical prostatectomy
      Lane BR, Lewicki P, Noyes SL, Labardee C, Meah S, Daignault-Newton S, Hafron J, Morgan TM, Radhakrishnan A, Dess RT, Montie J, Ghani KR, Ginsburg KB, Borza T. Cancer, 2026 Feb 15; 132 (4): DOI:10.1002/cncr.70291

    Featured News & Stories

         joe biden speaking
    Health Lab

    What does Joe Biden’s prostate cancer diagnosis mean for older patients?

    Based on former President Joe Biden's recent diagnosis, a Michigan Medicine urologists discusses routine screening procedures and treatment outcomes.
         medical glove purple behind patients back being put on
    Health Lab

    More men with prostate cancer are avoiding unnecessary surgery

    Researchers at University of Michigan showed that the proportion of patients undergoing prostatectomy for the lowest risk type of cancer dropped over fivefold between 2010 to 2024.